Recombinant TNFRSF12A (Enavatuzumab Biosimilar) anticorps

N° du produit ABIN7597658

Cet anticorps anti-TNFRSF12A (Enavatuzumab Biosimilar) est un anticorps Chimeric produit chez le Humanized, détectant TNFRSF12A (Enavatuzumab Biosimilar) dans not_set. Convient pour Humain.

Aperçu rapide pour Recombinant TNFRSF12A (Enavatuzumab Biosimilar) anticorps (ABIN7597658)

Antigène: TNFRSF12A (Enavatuzumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Humanized

Clonalité: Chimeric

Conjugué: Cet anticorp TNFRSF12A (Enavatuzumab Biosimilar) est non-conjugé

Application: Veuillez nous consulter SVP

Classe de qualité: Research Grade

Détail du produit anti-TNFRSF12A (Enavatuzumab Biosimilar) anticorps

Expression System: Mammalian cells

Fonction: Research Grade Enavatuzumab Biosimilar Antibody

Specificité: FGF-inducible 14, TNFRSF12A, FN14, CD266, TweakR, Fibroblast growth factor-inducible immediate-early response protein 14, Tweak-receptor, Tumor necrosis factor receptor superfamily member 12A

Purification: Protein A or G purified from cell culture supernatant.

Pureté: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 3.33 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Stock: 4 °C,-20 °C,-80 °C

Stockage commentaire: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Date de péremption: 12 months

Détails sur TNFRSF12A (Enavatuzumab Biosimilar)

Antigène: TNFRSF12A (Enavatuzumab Biosimilar)

Autre désignation: Enavatuzumab Biosimilar

Classe de substances: Biosimilar

Sujet: FGF-inducible 14, TNFRSF12A, FN14, CD266, TweakR, Fibroblast growth factor-inducible immediate-early response protein 14, Tweak-receptor, Tumor necrosis factor receptor superfamily member 12A

UniProt: Q9NP84

Numéro CAS: 1062149-33-0